BrainsWay Ltd. BWAY Stock
BrainsWay Ltd. Price Chart
BrainsWay Ltd. BWAY Financial and Trading Overview
| BrainsWay Ltd. stock price | 9.21 USD |
| Previous Close | 2.13 USD |
| Open | 2.15 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1800 |
| Day's Range | 2.15 - 2.28 USD |
| 52 Week Range | 1.38 - 7 USD |
| Volume | 18.79K USD |
| Avg. Volume | 66.4K USD |
| Market Cap | 40.07M USD |
| Beta (5Y Monthly) | 0.179452 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.5 USD |
BWAY Valuation Measures
| Enterprise Value | -7336072 USD |
| Trailing P/E | N/A |
| Forward P/E | -14.125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.5511602 |
| Price/Book (mrq) | 0.9142395 |
| Enterprise Value/Revenue | -0.284 |
| Enterprise Value/EBITDA | 0.529 |
Trading Information
BrainsWay Ltd. Stock Price History
| Beta (5Y Monthly) | 0.179452 |
| 52-Week Change | -49.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7 USD |
| 52 Week Low | 1.38 USD |
| 50-Day Moving Average | 1.69 USD |
| 200-Day Moving Average | 2.37 USD |
BWAY Share Statistics
| Avg. Volume (3 month) | 66.4K USD |
| Avg. Daily Volume (10-Days) | 116.39K USD |
| Shares Outstanding | 16.58M |
| Float | 12.76M |
| Short Ratio | 0.67 |
| % Held by Insiders | 5.03% |
| % Held by Institutions | 31.25% |
| Shares Short | 45.66K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -53.37% |
| Operating Margin (ttm) | -57.55% |
| Gross Margin | 72.69% |
| EBITDA Margin | -53.69% |
Management Effectiveness
| Return on Assets (ttm) | -13.75% |
| Return on Equity (ttm) | -27.95% |
Income Statement
| Revenue (ttm) | 25.83M USD |
| Revenue Per Share (ttm) | 1.63 USD |
| Quarterly Revenue Growth (yoy) | -16.90% |
| Gross Profit (ttm) | 20.05M USD |
| EBITDA | -13871000 USD |
| Net Income Avi to Common (ttm) | -13787000 USD |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 44.32M USD |
| Total Cash Per Share (mrq) | 2.55 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.127 |
| Book Value Per Share (mrq) | 2.472 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10314000 USD |
| Levered Free Cash Flow (ttm) | -8621250 USD |
Profile of BrainsWay Ltd.
| Country | United States |
| State | N/A |
| City | Jerusalem |
| Address | Bynet Building |
| ZIP | 9777518 |
| Phone | 972 2 582 4030 |
| Website | https://www.brainsway.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 134 |
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Q&A For BrainsWay Ltd. Stock
What is a current BWAY stock price?
BrainsWay Ltd. BWAY stock price today per share is 9.21 USD.
How to purchase BrainsWay Ltd. stock?
You can buy BWAY shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BrainsWay Ltd.?
The stock symbol or ticker of BrainsWay Ltd. is BWAY.
Which industry does the BrainsWay Ltd. company belong to?
The BrainsWay Ltd. industry is Medical Devices.
How many shares does BrainsWay Ltd. have in circulation?
The max supply of BrainsWay Ltd. shares is 18.87M.
What is BrainsWay Ltd. Price to Earnings Ratio (PE Ratio)?
BrainsWay Ltd. PE Ratio is 51.16666400 now.
What was BrainsWay Ltd. earnings per share over the trailing 12 months (TTM)?
BrainsWay Ltd. EPS is 0.18 USD over the trailing 12 months.
Which sector does the BrainsWay Ltd. company belong to?
The BrainsWay Ltd. sector is Healthcare.
BrainsWay Ltd. BWAY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Market Composite NQGM | 1839.71 USD — |
-3.16
|
— — | 1825.54 USD — | 1881.06 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}